全文获取类型
收费全文 | 13237篇 |
免费 | 1398篇 |
国内免费 | 59篇 |
专业分类
耳鼻咽喉 | 148篇 |
儿科学 | 356篇 |
妇产科学 | 313篇 |
基础医学 | 1776篇 |
口腔科学 | 453篇 |
临床医学 | 1907篇 |
内科学 | 2196篇 |
皮肤病学 | 227篇 |
神经病学 | 1097篇 |
特种医学 | 651篇 |
外国民族医学 | 3篇 |
外科学 | 1873篇 |
综合类 | 331篇 |
一般理论 | 9篇 |
预防医学 | 1180篇 |
眼科学 | 214篇 |
药学 | 1077篇 |
中国医学 | 10篇 |
肿瘤学 | 873篇 |
出版年
2021年 | 136篇 |
2019年 | 151篇 |
2018年 | 196篇 |
2017年 | 160篇 |
2016年 | 162篇 |
2015年 | 187篇 |
2014年 | 254篇 |
2013年 | 380篇 |
2012年 | 500篇 |
2011年 | 534篇 |
2010年 | 334篇 |
2009年 | 338篇 |
2008年 | 502篇 |
2007年 | 591篇 |
2006年 | 566篇 |
2005年 | 512篇 |
2004年 | 505篇 |
2003年 | 483篇 |
2002年 | 523篇 |
2001年 | 491篇 |
2000年 | 503篇 |
1999年 | 439篇 |
1998年 | 211篇 |
1997年 | 198篇 |
1996年 | 222篇 |
1995年 | 195篇 |
1994年 | 184篇 |
1993年 | 164篇 |
1992年 | 312篇 |
1991年 | 307篇 |
1990年 | 306篇 |
1989年 | 292篇 |
1988年 | 300篇 |
1987年 | 274篇 |
1986年 | 284篇 |
1985年 | 283篇 |
1984年 | 196篇 |
1983年 | 166篇 |
1982年 | 103篇 |
1981年 | 125篇 |
1980年 | 108篇 |
1979年 | 180篇 |
1978年 | 117篇 |
1977年 | 125篇 |
1976年 | 115篇 |
1975年 | 99篇 |
1974年 | 108篇 |
1973年 | 108篇 |
1972年 | 110篇 |
1968年 | 113篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
A comparison of cortisporin and ciprofloxacin otic drops as prophylaxis against post-tympanostomy otorrhea 总被引:4,自引:0,他引:4
Morpeth JF Bent JP Watson T 《International journal of pediatric otorhinolaryngology》2001,59(2):99-104
This study reports the evolution of a newborn hearing screening program which began in 1988. Data are reported from the period of time that universal newborn hearing screening was initiated, i.e. April 1996 to December 2000 (total screened=7128 babies). From 1996 to the present, the program has developed to the current form. During 2000, 1713 infants in the well-baby nursery and neonatal intensive care unit were screened at a cost of 18.44 dollars per child. Thirty (1.7%) infants failed the screen, of which 26 (86%) returned for follow-up testing. Fifteen infants were documented with hearing loss, 10 with conductive and five with sensorineural losses. The false positive rate was 0.96% and the overall sensorineural impairment rate was 1/343. 相似文献
992.
Tom Manly Vicki Anderson Ian Nimmo-Smith Anna Turner Peter Watson & Ian H. Robertson 《Journal of child psychology and psychiatry, and allied disciplines》2001,42(8):1065-1081
"Attention" is not a unitary brain process. Evidence from adult studies indicates that distinct neuroanatomical networks perform specific attentional operations and that these are vulnerable to selective damage. Accordingly, characterising attentional disorders requires the use of a variety of tasks that differentially challenge these systems. Here we describe a novel battery, the Test of Everyday Attention for Children (TEA-Ch), comprising nine subtests adapted from the adult literature. The performance of 293 healthy children between the ages of 6 and 16 is described together with the relationships to IQ, existing measures of attention, and scholastic attainment. This large normative sample also allows us to test the fit of the adult model of functionally separable attention systems to the observed patterns of variance in children's performance. A Structural Equation Modelling approach supports this view. A three-factor model of sustained and selective attention and higher-level "executive" control formed a good fit to the data, even in the youngest children. A single factor model was rejected. There are behavioural and anatomical grounds to believe that Attention Deficit Disorder (ADD) is particularly associated with poor self-sustained attention and behavioural control. The TEA-Ch performance of 24 boys diagnosed with ADD presented here is consistent with this view. When performance levels on WISC-III subtests were taken into account, specific deficits in sustained attention were apparent while selective attention performance was within the normal range. 相似文献
993.
Hosseini S Pishnamazi S Sadrzadeh SM Farid F Farid R Watson RR 《Journal of medicinal food》2001,4(4):201-209
Asthma is characterized as a chronic inflammatory process. Pycnogenol((R)), a bioflavonoid mixture extracted from Pinus maritima, is known to scavenge free radicals while possessing antioxidant and antiinflammatory properties. The objective of this study was to evaluate the efficiency of this agent in a randomized, double-blinded, placebo-controlled, crossover study in patients with varying asthma severity. Twenty-six patients who fulfilled the American Thoracic Society criteria for asthma were enrolled in the study. Medical history, physical examination, blood sample analyses, and spirometric values were obtained at baseline, 4 weeks, and 8 weeks. The patients were randomly assigned to receive either 1 mg/lb/day (maximum 200 mg/day) Pycnogenol or placebo for the first period of 4 weeks and then crossed over to the alternate regimen for the next 4 weeks. No adverse effects were observed related to the study drug. Within the contingent of 22 patients who completed the study, almost all responded favorably to Pycnogenol in contrast to placebo. Pycnogenol treatment also significantly reduced serum leukotrienes compared with placebo. The results of this pilot study indicate that Pycnogenol may be a valuable nutraceutical in the management of chronic asthma. We recommend that further clinical trials be conducted in larger groups of asthmatics to establish its efficacy. 相似文献
994.
A 7 year prospective comparative study of three topical beta blockers in the management of primary open angle glaucoma 总被引:1,自引:0,他引:1
下载免费PDF全文
![点击此处可从《The British journal of ophthalmology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
AIM: To determine the long term efficacy of monotherapy with topically applied beta blocking agents and to determine whether selective beta blockers were able to preserve the visual field more effectively than non-selective agents. METHOD: A prospective randomised, open, comparative study of three topically applied beta blockers-timolol, betaxolol, and carteolol-was carried out on 153 patients (280 eyes) with newly diagnosed open angle glaucoma. Those patients who were not withdrawn were followed by the same observers for a minimum of 2 years and a maximum of 7 years, with clinical observations, Goldmann tonometry and 24.2 Humphrey visual field analysis. RESULTS: All three drugs lowered the IOP significantly from untreated levels but betaxolol took up to 12 months in some instances to reach the maximum pressure reduction. After 7 years only 43% of the eyes begun on timolol, 34% of those started on carteolol, and 29% of those on betaxolol were still being treated with these medications alone. Visual fields were analysed throughout the trial by CPSD and MD and at the end by linear regression analysis (PROGRESSOR). The visual fields remained the same without apparent improvement or deterioration throughout the period of follow up. Eight patients (11 eyes) were withdrawn because of continuing field loss in spite of reduction in IOP (six using carteolol and five using betaxolol). CONCLUSIONS: Analysis shows that less than half the eyes initially treated with topical beta blockers might be expected to still be being treated with their original medication after 5 years. The rest required either additional medication or trabeculectomy. There was no statistically significant improvement or deterioration in the visual fields over a 7 year period. On the evidence of this trial there are no particular advantages in using selective beta blockers. 相似文献
995.
This article reviews the evidence supporting different somatic treatment strategies in the acute and maintenance treatment phases of bipolar disorder. Bipolar affective disorder is a chronic disorder with a life time incidence of 0.3 - 1.5/100 [1]. Severe affective disorder is associated with a risk of completed suicide of 6 - 15% [2,3]. Traditionally, bipolar disorder has been considered as an episodic disorder with good inter-episode recovery [4]. This is being increasingly challenged with patients demonstrating social, marital, occupational and cognitive dysfunction, even when euthymic [5]. The management of bipolar disorder should be considered in the context of; the type of episode, this may be manic, depressed or mixed; the degree and rate of recovery; the cycling frequency and precipitant, if any, for recurrence and the onset and evolution of the underlying illness. On average, four episodes occur every 10 years. However 13 - 24% of patients develop rapid cycling disorder, in which four or more episodes occur within a year. Patients with bipolar disorder often have co-morbid anxiety and substance abuse. Moreover, axis I co-morbidity may be associated with an earlier age at onset and worsening course of bipolar illness. [6]. Axis II co-morbidity is also common, this was highlighted in a study by Kay and colleagues who, after excluding patients with a history of alcohol misuse, demonstrated axis II co-morbidity in almost a quarter of euthymic bipolar patients [7]. Good practice relies on an overall management plan that incorporates somatic, psychological and social approaches. This paper will focus on one element of such a plan, the currently available somatic management strategies for bipolar disorder. 相似文献
996.
Szeremeta M Dawson J Manning D Watson AR Wright MM Notcutt W Lancaster R 《Journal of medical ethics》2001,27(Z1):i9-17
Each of the following papers gives an account of a different UK clinical ethics committee. The committees vary in the length of time they have been established, and also in the main focus of their work. The accounts discuss the development of the committees and some of the ethical problems that have been brought to them. The issues raised will be relevant for other National Health Service (NHS) trusts in the UK that wish to set up such a committee. 相似文献
997.
Hypergastrinemia promotes adenoma progression in the APC(Min-/+) mouse model of familial adenomatous polyposis 总被引:6,自引:0,他引:6
Serum hypergastrinemia promotes the growth of colorectal adenocarcinoma. Some colorectal adenomas express cholecystokinin B/gastrin receptor mRNA, and thus hypergastrinemia may increase progression through the adenoma-carcinoma sequence. This was investigated in the multiple intestinal neoplasia APC(Min-/+) mouse. Serum gastrin levels in APC(Min-/+) mice were elevated 5-6-fold by oral administration of omeprazole (75 mg/kg). Terminal tumor burden was monitored by onset of anemia. A labeling index was generated by immunohistochemical detection of bromodeoxyuridine incorporation. Serum gastrin was neutralized by antigastrin antibodies raised in situ by use of a gastrin immunogen, Gastrimmune. Hypergastrinemia resulted in reduced survival of the APC(Min-/+) mice from a median survival of 13 weeks in the controls to 10 weeks following omeprazole treatment (P < 0.00001, log-rank test). The labeling indices of adenomas from the small and large intestines of omeprazole-treated mice were increased 35 and 29%, respectively (P < 0.05 and P < 0.025, respectively). Gastrimmune immunization reversed both the survival effect and the increased proliferation resulting from serum hypergastrinemia. Hypergastrinemia may promote the progression of existing premalignant colonic lesions by increasing proliferation. Clinical investigations should determine whether this occurs in the human scenario, considering the widespread use of proton pump inhibitors. 相似文献
998.
999.
Expression profiling reveals hepsin overexpression in prostate cancer 总被引:21,自引:0,他引:21
Magee JA Araki T Patil S Ehrig T True L Humphrey PA Catalona WJ Watson MA Milbrandt J 《Cancer research》2001,61(15):5692-5696
Prostate cancer is the most commonly diagnosed noncutaneous cancer in men. Despite this fact, many of the genetic changes that coincide with prostate cancer progression remain enigmatic. We have addressed this problem by characterizing the expression profiles of several benign and malignant human prostate samples, and we have identified several genes that are differentially expressed between benign and malignant glands. One gene that was overexpressed encodes the serine protease hepsin. We used an independent sample set to confirm that hepsin is overexpressed in prostate tumors, and in situ hybridization demonstrates that hepsin is specifically overexpressed in the carcinoma cells themselves. These facts, together with the molecular properties of hepsin, make it an ideal target for prostate cancer therapy. 相似文献
1000.
Genetic alterations in bronchial mucosa and plasma DNA from individuals at high risk of lung cancer 总被引:9,自引:0,他引:9
Allan JM Hardie LJ Briggs JA Davidson LA Watson JP Pearson SB Muers MF Wild CP 《International journal of cancer. Journal international du cancer》2001,91(3):359-365
Evidence suggests that the majority of lung cancer patients have tumour-derived genetic alterations in circulating plasma DNA, and that this may be developed as a diagnostic tool. To this end, we have studied 60 individuals attending bronchoscopy clinic, with symptoms suspicious of lung cancer, for genetic alterations in bronchial mucosa biopsy (n = 47) and plasma (n = 40) DNA. Thirteen of 47 individuals from whom biopsies were taken displayed allelic loss of heterozygosity (LOH) in biopsy DNA for at least 1 of 4 markers. All 13 of these individuals had neoplastic tumour cells in their biopsies and were subsequently diagnosed with cancer. Thirteen of 40 individuals from whom plasma was taken displayed a plasma DNA LOH, and 12 of these 13 individuals were subsequently diagnosed with cancer. LOH in plasma was generally representative of LOH in the corresponding biopsy. In terms of sensitivity, using just 4 markers, biopsy LOH and plasma LOH were found in 13 of 44 (30%) and 12 of 29 (41%), respectively, of those patients subsequently diagnosed with cancer. Two patients were positive for LOH in plasma samples that pre-dated a diagnosis of cancer by several months. These data suggest that assay of genetic alterations in circulating plasma DNA may be developed as a useful addition to conventional techniques for the diagnosis of lung cancer. 相似文献